Myval™ transcatheter heart valve (THV) is designed for the treatment of patients with aortic stenosis. The valve's unique "hybrid honeycomb" design with PET technology provides superior hemodynamic performance and minimizes paravalvular leakage. Myval THV is designed for precise positioning and reliable deployment, providing optimal clinical outcomes in patients with severe aortic stenosis. Available in a wide range of sizes to accommodate individual anatomical features.